Second-line, post-docetaxel therapy for advanced, androgen deprivation-refractory prostate cancer
about
Second-line, post-docetaxel therapy for advanced, androgen deprivation-refractory prostate cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Second-line, post-docetaxel th ...... ion-refractory prostate cancer
@ast
Second-line, post-docetaxel th ...... ion-refractory prostate cancer
@en
Second-line, post-docetaxel th ...... ion-refractory prostate cancer
@en-gb
Second-line, post-docetaxel th ...... ion-refractory prostate cancer
@nl
type
label
Second-line, post-docetaxel th ...... ion-refractory prostate cancer
@ast
Second-line, post-docetaxel th ...... ion-refractory prostate cancer
@en
Second-line, post-docetaxel th ...... ion-refractory prostate cancer
@en-gb
Second-line, post-docetaxel th ...... ion-refractory prostate cancer
@nl
prefLabel
Second-line, post-docetaxel th ...... ion-refractory prostate cancer
@ast
Second-line, post-docetaxel th ...... ion-refractory prostate cancer
@en
Second-line, post-docetaxel th ...... ion-refractory prostate cancer
@en-gb
Second-line, post-docetaxel th ...... ion-refractory prostate cancer
@nl
P2093
P2860
P1476
Second-line, post-docetaxel th ...... ion-refractory prostate cancer
@en
P2093
Alberto Trinchieri
Elena Monti
Emanuela Marras
Gianpaolo Perletti
Paul S Rennie
Vittorio Magri
P2860
P356
10.1002/14651858.CD009998.PUB2
P577
2014-11-13T00:00:00Z